1. Home
  2. Blog
  3. Axol Bioscience Expanding Account Management Team
Axol-Bioscience-human-iPSC-image-A-sit-down-with-Steve-Rees-the-importance-of-understanding-renal-toxicity-in-drug-development.jpeg

Axol Bioscience Expanding Account Management Team

Axol Bioscience Expanding Account Management Team

Axol-Bioscience-human-iPSC-image-A-sit-down-with-Steve-Rees-the-importance-of-understanding-renal-toxicity-in-drug-development.jpeg
Axol-Bioscience-human-iPSC-image-default-Prod.jpg

Axol Bioscience Expanding Account Management Team in the US

Introducing Mark Dahlquist 
Technical Account Manager – Western US

Mark Dahlquist recently joined Axol Bioscience on November 16, 2020 as Technical Account Manager covering the West Coast and Central United States. Mr. Dahlquist’s focus is to grow sales for quality iPSC derived cells lines and related media along with best in class services such as stem cell reprogramming, differentiation, gene editing, and electrophysiology. Mr. Dahlquist is an experienced results-driven life science sales professional with 27 years of experience in life science both in sales, marketing, and at the bench. Prior to joining Axol Bioscience, Mr. Dahlquist spent over 21 years with Bio-Techne, of which 18 years he was selling cell culture reagents, antibodies, and immunoassays to academic, pharmaceutical, biotech, and diagnostic accounts. Mr. Dahlquist received a Bachelor of Science in Genetics and Cell Biology at the University of Minnesota Twin Cities. Mr. Dahlquist is proud to have started his life science journey in the laboratory of Dr. Perry Hackett where at the time the Sleeping Beauty transposon was discovered and “awakened,” and has since been adopted for genome engineering over the years. In his spare time, Mark is an avid trout fisherman, motorcycle enthusiast, loving father to his 14-year-old son Matthew.

Previous
Introduction of MEA screening services for human iPSC-derived cells
Next
Hiring Senior Scientist / Team Leader